Combined analysis of RIP-seq and RNA-seq data, we identified USP39 facilitates efficient splicing of HMGA2 and that USP39 exerts oncogenic potential partially through regulating HMGA2 in ovarian cancer cells (Fig. 7). Here, USP39 is linked to ovarian cancer.